Noteworthy News Articles on Mental Health Topics, August 1-8, 2006
What is the "culture of affluence," and why is it damaging to kids? Affluent communities aren't new, nor is academic competition or drug abuse. In the late 1960s and early 1970s competition for college was fierce, drug use was common and, for boys, there was the added fear of being drafted to fight in Vietnam. Why would life be harder for teenagers now? Are the increases in depression, anxiety disorders and substance abuse real, or do they reflect the fact that affluent kids are more likely to be diagnosed and medicated than their less privileged peers? Why are many parents pathologically over-involved? You identify three types of parents: involved, over-involved and intrusive. How do they differ? What advice do you have for parents?
Jane Gross, New York Times- 8/3/2006 They spend decades denying their sexual confusion to themselves and others. They generally limit their encounters with men to anonymous one-night stands and tell all manner of lies if their wives suspect. They consider themselves to be devoted husbands, conscientious fathers and suburban homeowners, and what typically brings them to the point of crisis in their 40’s, 50’s and even 60’s is their first emotional connection with another man. For gay men in heterosexual marriages, even after the status quo becomes unbearable, the pull of domestic life remains powerful. Many are desperate to preserve their marriages — to continue reaping the emotional and financial support of wives, and domestic pleasures like tucking children in at night. The demand for support groups for gay, married men, as well as traffic in Internet chat rooms, shows that so-called “Brokeback” marriages have hardly disappeared, as many experts assumed they would, even in an age when gay couples, in certain parts of the country, live openly and raise children just like any family. Leaving a marriage and setting up housekeeping with a gay partner is not what most married gay men have in mind when they join a support group, according to Stephen McFadden, a clinical social worker, who runs such groups in Manhattan. Instead, Mr. McFadden and others in the field say, their clients generally start out committed to the opposite goal. Even after a pained awakening or acknowledgment of their sexual orientation, these men want to save their marriages, Mr. McFadden and others say, either by lying, promising their wives they will not have sex with men or persuading them to accept their double lives. Yet, such arrangements succeed for only “a small percentage’’ of couples, Mr. McFadden and other therapists said, but the stubborn attempt often makes these men unwelcome or uncomfortable in support groups for gay fathers, which are easy to find but largely the province of men who are long divorced. One support group member, Steve T., is a Long Island doctor, married to his high school sweetheart and the father of three school-age sons. He said he felt the sting of judgment when he tried a group for gay fathers. “They thought my desire to stay married was part of my denial,’’ said Dr. T., who would do almost anything to keep his family together and his suburban lifestyle intact, even after telling his wife that he is gay. She is his “best friend’’ and the “perfect co-parent,’’ said the 44-year-old doctor, who agreed to be interviewed on condition he not be fully identified and his secrets thus revealed to relatives, neighbors and patients. He enjoys the social life of a popular suburban couple, adores his in-laws and wants to live in the same home as his children. But he also wants to continue a love affair with a man like himself: married, with children, a lawn to mow and a comfortable life. And until a few weeks ago, Dr. T. said, “this was working great in terms of getting our needs met and not disrupting our families.’’ Dr. T.’s wife had agreed she could live with his sexual orientation provided he didn’t act on it. So he lied and said his homosexual relationship did not include sex. But she wasn’t fooled and forced him to move into an in-law apartment in the family home, a way station to a more formal separation. This development has left him stunned, one moment sympathetic to his wife’s position and the next disbelieving that they can’t work it out. “I love her, but she wants me to be in love with her,” Dr. T. said. “She wants to be my one and only. Everything we have will be at risk if, God forbid, we divorce.’’ Data on these marriages is scarce and unreliable because of the various ways of defining “gay’’ in demographic research. Studies in the 1970’s and 80’s, using inconsistent methodology, found anywhere from one-fifth to one-third of gay men were or had at one time been married. All the therapists and gay men interviewed for this article assumed that percentage would be far lower in today’s more accepting society. But Gary J. Gates, a demographer at the Williams Institute, a research group that studies gay issues at U.C.L.A., blended data for The New York Times from the 2000 Census and a 2002 federal survey of family configurations, and found that the percentage of gay men who had ever been married could be as high as 38 percent — or as low as 9 percent — depending on whether respondents were asked their sexual orientation, whom they had sex with or whom they found attractive. Of the 27 million American men currently married, Mr. Gates found, 1.6 percent, or 436,000, identify themselves as gay or bisexual. Of the 75 million men who have ever been married, 1.8 percent, or 1.3 million, identify themselves that way. But, in both cases, when the men are asked about behavior if they have ever had sex with men, not what they consider their sexual orientation, the number of men who have ever been married doubles. The sort of arrangement Dr. T. hoped for — a proper marriage and one or more relationships with men on the side — is not unheard of. Cole Porter pulled it off and so did James McGreevey, New Jersey’s former governor, who left office, and his wife, in 2004. Mr. McGreevey, 48, has spent the last year writing a memoir, “The Confession,’’ to be released on Sept. 19, and recently, with his new partner, Mark O’Donnell, 42, moved into a Georgian mansion in Plainfield, N.J. The specter of AIDS has led to a formal and presumably safe way for gay married men to have it all, known as a Closed-Loop Relationship. Instead of risky promiscuous sex, a married man has two “monogamous’’ relationships, one with his wife and one with another man, usually married. Done according to the rules, enumerated on Web sites and online support groups, all four parties agree to this setup. “It’s an approach which people hoped would be a compromise solution,’’ said Michael, the Web master of www.marriedgay.org, a site based in Manchester, England, who declined to give his last name out of deference to his wife, whom he no longer lives with. “But it’s easier said than done.’’ Closed-Loop Relationships are anathema to Bonnie Kaye, the former wife of a gay man, who runs the Web site www.gayhusbands.com and conducts “How to Come Out to Your Wife’’ workshops. “If they’re too selfish to leave, I won’t work with them,’’ Ms. Kaye said. “If they love their wives, they need to give them their lives back.’’ Deception remains common. An unscientific survey of visitors to www.marriedgay.org found that more than half of the married gay respondents said their wives did not know of their sexual inclinations. Of those, a slim majority were considering whether to come clean but a third said “never.’’ Men who are forthcoming with their wives, and then divorce or separate, report surprise that what happens afterward is often vastly harder than the process of ending the marriage. Scott W., 64, a retired school teacher and real estate agent, relieved his occasional need for homosexual sex with anonymous encounters on East Hampton Beach without quite labeling himself as gay or bisexual. Only when he fell for someone, who rejected him because he was married, did Scott conclude he had to divorce a woman he loved and had been with for 24 years. That process, as these things go, was without acrimony, said Scott, a former member of Mr. McFadden’s support group, and he remains close to her and his two grown sons. But looking for love in late middle age, Scott said, is a frustrating ordeal. After a brief “slut phase,’’ he had “the naïve idea I’d find someone right away.’’ Instead, he has learned he is ill-suited, or too old, for gay night life. “They want to go out at 11 o’clock,’’ Scott said, “and I want to go to sleep at 11 o’clock. Plus, in those places, there’s too much noise and confusion.’’ He eats dinner most nights at the bar of an East Side restaurant that attracts an older gay clientele. The conversation is lively, Scott said, but he hasn’t found anyone to date. Recently, a married gay man left his business card but Scott threw it away. He is not looking for a one-night stand. Scott’s loneliness after divorce is common among middle-aged men, according to Dr. Richard A. Isay, 69, the first openly gay member of the American Psychoanalytic Association who himself left a heterosexual marriage about 20 years ago, when he was already in a gay relationship that he remains in today. Dr. Isay said he came slowly to understand his patients’ sense of isolation during three decades of practice, and therefore has modified his advice to gay married men. “I beg them to take it slow because it’s difficult to find the substitute for the love and companionship of a longtime spouse,’’ said Dr. Isay, author of “Commitment and Healing: Gay Men and the Need for Romantic Love” (Wiley, 2006). “They must take that loss into consideration.’’ The loss comes on top of the adolescent awkwardness of not knowing the social norms of a new world, described on the blog www.comingoutat48.blogspot.com. Its author, who identifies himself only as Chris, writes of changing his clothes many times before heading to his first gay bar, finding it empty and not realizing he had arrived too early. He writes of not understanding the sexual terminology in gay personal ads and looking for an “always gay’’ man to teach him what he needed to know. In an e-mail exchange, Chris compared the experience to “living abroad,’’ where the “thrill of a new place’’ competes with “the deep loneliness’’ of unfamiliarity. It is not, he said “the existential loneliness of not knowing who you are and where you belong, but the loneliness of ‘What am I going to do this weekend?’ ‘How am I supposed to behave?’ or ‘When will the phone start to ring?’ ’’ Even in the security of a six-year relationship with a man, John. J., 53, resists divorcing his wife of 30 years. “I am still so in love with her,’’ he said, speaking on the condition he not be fully identified because his parents, in-laws and colleagues do not know the details of his separation. “And there’s nobody else I’d use that word for.’’ John said he had no moral choice but to leave his marriage once he “let the emotional aspect’’ of his attraction to men into his life. “That had been the realm of me and my wife,’’ he said. “So that’s the line of demarcation. The two, for me, are mutually exclusive. But divorce? I can’t imagine the finality of that. I have doubts all the time.’’
Associated Press, 78/6/2006 When Gina O'Brien decided she no longer needed drugs to quell her anxiety and panic attacks, she followed doctor's orders by slowly tapering her dose of the antidepressant Paxil. The gradual withdrawal was supposed to prevent unpleasant symptoms that can result from stopping antidepressants cold turkey. But it didn't work. ''I felt so sick that I couldn't get off my couch,'' O'Brien said. ''I couldn't stop crying.'' Overwhelmed by nausea and uncontrollable crying, she felt she had no choice but to start taking the pills again. More than a year later the Michigan woman still takes Paxil, and expects to be on it for the rest of her life. In the almost two decades since Prozac -- the first of the antidepressants known as SRIs, or serotonin reuptake inhibitors -- hit the market, a number of patients have reported extreme reactions to discontinuing the drugs. Two of the best-selling antidepressants -- Effexor and Paxil -- have led to so many complaints that some doctors avoid prescribing them altogether. ''It's not that we never use it, but in the end I will tend not to prescribe Effexor or Paxil,'' said Dr. Richard C. Shelton, a psychiatrist at the Vanderbilt University School of Medicine. Shelton has received grant support from the makers of both drugs and consulted for a number of other pharmaceutical companies. Patients report experiencing all sorts of symptoms, sometimes within hours of stopping their medication. They can suffer from flu-like nausea, muscle aches, uncontrollable crying, dizziness and diarrhea. Many patients suffer ''brain zaps,'' bizarre and briefly overwhelming electrical sensations that propagate from the back of the head. Though not exactly painful, they are briefly disorienting and can be terrifying to patients who don't know what they are experiencing. There are case reports of people who have just quit antidepressants showing up in hospital emergency rooms, thinking they are suffering from seizures. Toni Wilson certainly didn't know how unpleasant going off Zoloft could be when her doctor recently switched her to Wellbutrin, telling her that the new drug would ''take the place of'' the old one. The two antidepressants actually work on entirely different neurochemical systems, so going straight from one to the other was equivalent to quitting Zoloft cold turkey. ''After about three days I felt real anxious and irritable,'' the Kansas woman said in an e-mail message. ''I would shake, not eat much, it felt like little needles in my body and head.'' Cases like Wilson's would be virtually nonexistent if physicians took more care in weaning their patients off antidepressants, said Philip Ninan, vice president for neuroscience at Wyeth, the maker of Effexor. ''The management of discontinuation symptoms is relatively easy if you know about it,'' Ninan said, and noted that Wyeth had made efforts to educate both physicians and patients. Yet surprisingly few doctors know enough about SRI discontinuation to manage it effectively. A 1997 survey of English doctors found that 28 percent of psychiatrists and 70 percent of general practitioners had no idea that patients might have problems after discontinuing antidepressants. Awareness may have increased since then, but the phenomenon is so little studied that no one has done the necessary research to find out. The condition's prevalence is equally mysterious. Studies put the rate at anywhere from 17 percent to 78 percent for the most problematic drugs. So little is known about it that researchers aren't even exactly sure what causes the symptoms. It may be related to the fact that the brain chemical affected by most of the antidepressants on the market today, serotonin, does a lot more than regulate mood. It is also involved in sleep, balance, digestion and other physiological processes. So when you throw the brain's serotonin system out of whack, which is essentially what you're doing by either starting or discontinuing an antidepressant, virtually the whole body can be affected. Generally the drugs that are metabolized most quickly cause more severe symptoms, Shelton said. Effexor, which breaks down in a period of hours, is one of the worst SRIs in that regard; Prozac, which has a half-life of about a week, is considered the best. Some doctors have been able to minimize withdrawal symptoms in patients who are quitting Effexor or Paxil by gradually switching them over to Prozac, then tapering them off the more easily discontinued drug. Critics of the pharmaceutical industry complain that drug companies downplay the severity of drug discontinuation symptoms. The prescribing information companies provide to doctors warns that patients occasionally experience mild symptoms when they stop taking SRI antidepressants, but imply that tapering off the medication can prevent problems. Medical journals describe the ill effects of going off the drugs as ''mild and short-lived,'' and usually avoidable if the dose is tapered. ''I don't think they're difficult to go off,'' said Alan Schatzberg, chairman of the department of psychiatry and behavioral sciences at the Stanford University School of Medicine. ''The vast majority of people aren't that sensitive.'' Schatzberg recently chaired a Wyeth-sponsored panel of physicians that offered guidelines for how to manage ''antidepressant discontinuation syndrome,'' the preferred medical term for what a layperson would think of as withdrawal. He has also served as a consultant to several other pharmaceutical companies. Terms like ''antidepressant discontinuation syndrome'' demonstrate the pharmaceutical industry's efforts to downplay the problem, charged Karen Menzies, an attorney who has been involved in litigation over the phenomenon. ''Withdrawal is the word that is used in Europe,'' she said. In December 2004 Britain's drug regulatory agency issued a report that warned that all SRIs ''may be associated with withdrawal'' and noted that Paxil and Effexor ''seem to be associated with a greater frequency of withdrawal reactions.'' But drug companies insist antidepressants can't cause withdrawal because they are not technically addictive. Even so, many patients who have gone through the experience say it feels like withdrawal to them. Some can't work, drive, socialize or do other everyday things for weeks. ''You just feel awful,'' said a New York children's entertainer, who asked not to be named for professional reasons. He has taken a small dose of Effexor for eight years rather than suffer through the withdrawal experience. But he said the inconvenience is worth it for the benefits the drug provided him when he needed it. Taking SRIs indefinitely is not an attractive option for many patients because it means putting up with unpleasant side-effects such as weight gain and sexual dysfunction. For women who want to have children it's an especially risky choice; researchers have documented withdrawal in newborns whose mothers were taking antidepressants, and some SRIs have been linked to birth defects. Having to keep taking Paxil makes O'Brien angry because she feels at the mercy of GlaxoSmithKline, the company that makes it. Though a GSK spokesperson said the symptoms associated with discontinuing Paxil are generally mild and manageable, in O'Brien's eyes the company is profiting by having hooked her on one of its drugs. ''If they ever did quit making Paxil, I'd be in so much trouble,'' O'Brien said. ''What really makes me mad is if I can't get off it, why am I paying them? They should be paying me.''
In the first of his serial apologies afterward — the one that did not mention the anti-Semitic nature of his rants — Mr. Gibson called what he said “despicable” and that he made statements “that I do not believe to be true.” In a follow-up apology that dealt directly with his comments about Jews, he said, “I am in the process of understanding where those vicious words came from during that drunken display.” So where, exactly, did those words come from? (And not just the anti-Jewish comments, but also the less-noted crude aside about the anatomy of a female officer?) Was this alcohol-fueled soliloquy an ugly insight into Mr. Gibson’s character — in other words, in vino veritas? Or was it just the tequila talking? Science, as it happens, has been hard at work trying to understand the how and the why of what everyone at a college mixer learns: alcohol can make people do, and say, stupid things. But does it make people say things that they do not believe at all, that are, as Mr. Gibson insisted in his statements, antithetical to one’s own views and faith? Experts generally suggest that the answer is “Nope.” When asked where those vicious words came from, Dr. Kevin J. Corcoran, a psychology researcher who has studied the effects of alcohol on perception and judgment, replied, simply, “his mouth.” Dr. Corcoran said comments do not spring from nothing; for example, Dr. Corcoran said, he himself would not make anti-Semitic statements under the influence of alcohol. “I say other outrageous things when I’m drunk,” he said. He added that Mr. Gibson “may not fully believe” his statements about Jews, “but they were waiting to be delivered,” once his inhibitions were lowered and he was subjected to the stress of being pulled over by the police. “We all have things that we might think or feel or even be attracted to that we know are wrong,” said Dr. Corcoran, who is also the dean of arts and sciences at Northern Kentucky University. For example, he said, people are likelier to look at pornography when they drink than when they are sober; alcohol reduces inhibitions, for good or ill. Alcohol suppresses the prefrontal cortex and the cerebellum regions of the brain, said Dr. Nora D. Volkow, the director of the National Institute on Drug Abuse, who declined to comment specifically on the Gibson case. The cerebellum governs motor coordination, which explains the drunk’s weaving walk and iffy driving skills. The prefrontal cortex “is normally making an assessment of the appropriateness of your acts,” she said, modulating desires and urges. After a couple of drinks, Dr. Volkow said, suppressing such impulses becomes much harder. “Alcohol brings you back into adolescence and childhood,” she said, the time before the prefrontal cortex is fully developed. This leads to a condition that researchers call the “alcohol myopia effect,” in which someone who has had too much to drink reacts to immediate cues without regard to consequences or the broader social context. G. Alan Marlatt, director of the Addictive Behaviors Research Center at the University of Washington, said that psychologists often focus on the difference between “traits and states.” Inebriation is a temporary state, but it might unleash one’s deeper and more permanent traits, he said. Nonetheless, Mr. Marlatt said that he had encountered people who, under the influence of alcohol and other drugs, do completely uncharacteristic things or say things that are not true. He recalled a case of a man coming out of anesthesia — alcohol is an anesthetic, after all — and babbling about having an extramarital affair, even though he apparently had done nothing of the sort. Even in this case, however, Dr. Marlatt said that he wondered whether the patient’s words sprang from a desire to have an affair, whether there had been one or not. In Robert Louis Stevenson’s “Strange Case of Dr. Jekyll and Mr. Hyde,” Dr. Marlatt noted, the evil Hyde was no stranger to the good Dr. Jekyll; he sprang from within. Which is why the best explanation for Mr. Gibson’s comments may come from the exquisite Italian phrase for misspeaking. Instead of saying “oops,” they say “mi è scappato.” It means, literally, “It escaped from me.” Home Again After Foster Care Ofelia Casillas, Chicago Tribune- 8/6/2006 After 15 years as a ward of the state, Shantaye Wonzer had been through 16 foster homes and two residential treatment centers. She had slept on a porch in one home and in a kitchen chair at another. So Wonzer decided to return to the family she'd been taken from as a toddler. Now Wonzer, like dozens of other former foster children, is charting a new, still undefined relationship with her birth mother, whose drug habit years ago had made Wonzer a ward of the state. "I never thought I would be, but I'm here," said Wonzer, 18. "And I'm trying to make the best of it." In Illinois, foster children who reach age 18 can choose whether they want to leave the system, or remain a part of it until they are 21. The University of Chicago Chapin Hall Center for Children recently surveyed 386 such teens. One hundred and six had left the system. And of them, more than a third had returned home to live with their biological families, sometimes to the very parents who had neglected them. Despite entering the child-welfare system because of abuse or neglect at home, most of the youths in the study had stayed in touch with their relatives. Most reported feeling close to one or more family members, particularly grandparents, siblings and biological mothers. "It's surprising from the standpoint of general public perception and even to people in the system," said Mark Courtney, the center's director. Kendall Marlowe, spokesman for the Illinois Department of Children and Family Services, said his agency has not "taken a systemic look at what happens to children leaving care," but he said the Chapin Hall study is "an important first step" in helping his agency to better understand these youths. But returning home isn't necessarily a panacea, said Cook County Public Guardian Robert Harris. "You have nostalgia of what life was like before, or what it could have been," Harris said. "Sometimes it's a rude awakening." Many older teens--say, those home from college--struggle to balance parental support and their desire for independence. Former foster kids find that typical awkwardness multiplied by old wounds and the distance of years apart. Longing for family Erik Farley, 21, found a short stint living with his mother to be much different than the dreams he harbored while they were separated. As Farley tells it, his odyssey began when his mother was working long hours, leaving him and his brothers alone. Farley ended up with foster parents in Geneva. After they became his legal guardians, they moved to Virginia and, later, New York. But he always longed for his family in Illinois. "You know how you look up at the moon and wonder if they are looking at the moon too? That's what I would do," Farley said. "The nights when the moon was beautiful, I'd look up and wonder if they were looking." One month before he turned 18, Farley drove 16 hours home to his mother. But once he arrived, he longed for independence. "I didn't have that same love that a child has for his mother because we had grown so distant," he said. "She was my mother, and I loved her for that. She carried me for nine months. She was really strong when I was little. I respected her and loved her that she had raised me as best she could." Tenesha Adams, 22, felt she had no option in June but to move in with her grandmother--though she soon made an even more drastic choice. In one, government researchers found that an injection of a powerful anesthetic drug dissolved feelings of despair in a small group of severely depressed patients in a matter of hours, and that the effect lasted for up to a week in some participants. Doctors cautioned that the study was very small, and that the drug, ketamine, is a tightly controlled substance sometimes used as a club drug that can cause hallucinations, confusion and dangerous reactions, especially when ingested in unknown doses. In the other, psychiatrists in New York found evidence that antidepressant drugs significantly increased the risk that some children and adolescents would attempt or commit suicide. Doctors have debated this risk for years, but the authors of the study were skeptical of it, and their report may sway others. Both studies are being published in The Archives of General Psychiatry. In the first study, Dr. Carlos A. Zarate of the National Institute of Mental Health led a team of researchers who treated 18 chronically depressed men and women with the anesthetic ketamine. Five participants recovered from depression in the first day and were still significantly improved a week later. Most patients also received a placebo treatment during the study, an injection of saline solution, and showed no improvement. Dr. Zarate said experimenting with novel approaches was crucial because the current crop of antidepressant drugs worked slowly and weakly, if at all, for millions of patients. Ketamine affects the brain in a way entirely different from drugs like Prozac, and it has shown some antidepressant effects in animal studies. It had not been tried for depression in humans. “What the study tells us is that we can break this sound barrier, in effect, and get an almost immediate response that we cannot get with other drugs,” Dr. Zarate said. Ketamine is not approved for depression, and it has a checkered past in psychiatric research. The drug often induces hallucinations, like whispering voices and light trails, and researchers used it in the 1990’s to induce psychotic reactions in people with schizophrenia — an experiment widely criticized as unethical. Dr. Zarate said that neither doctors nor patients should use it for depression outside of carefully controlled research settings and that the results of the current trial should be considered suggestive. “This drug should be seen as a tool for understanding what mechanisms might be involved in rapid relief,” and not as a treatment, Dr. Zarate said. The study of suicide risk, led by Dr. Mark Olfson of Columbia University and the New York State Psychiatric Institute, was based on an analysis of Medicaid records of more than 4,400 people who were hospitalized for depression in 1999 and 2000. The researchers found no link between the antidepressant drugs and suicidal behavior in depressed patients 19 or older. But children and adolescents in the study who were taking antidepressants were about 50 percent more likely than those not on the drugs to try to kill themselves. And they were about 15 times as likely as those not on the medications to complete the act, although the number of suicides was too small to draw definitive conclusions, the authors cautioned. In addition, there could be differences between the two groups that the Medicaid records didn’t reveal: the children who received the drugs may have been more severely ill, skewing the results, they said. In 2004, the Food and Drug Administration required strong warnings on the labels of antidepressant drugs alerting parents and doctors of a possible suicide risk in some children. Since then many psychiatrists have been skeptical of the suicide link. “I was surprised by what we found,” Dr. Olfson said. “I set out thinking we’d find that the drugs” significantly reduced suicide risk. The findings may prompt researchers to look at which children are most at risk, rather than continuing to debate whether the risk exists, he said. Daniel Yi, Los Angles Times- 8/8/2006 Americans' growing reliance on prescription drugs to lull themselves to sleep has reignited debate about the role of commercials in influencing medical choices of patients and doctors. Use of prescription sleeping pills is up nearly 50 percent since 2001, and a report released Monday by Consumers Union, the publisher of Consumer Reports magazine, says at least part of the increase is because of a surge of direct-to-consumer advertising of such anti-insomnia medications as Ambien and Lunesta. Critics have long said that aggressive advertising by drug companies has resulted in rising health care costs and overuse of drugs, some of which might have dangerous side effects. What's different now with the new generation of prescription sleeping pills, critics say, is that their marketing may be inducing people to use medications unnecessarily. For those longing for a good night's sleep, they say, other remedies, such as over-the-counter medicines or even changes in habit, might work just as well or better. "We've always known there are people who suffer from insomnia. But what the advertising has done is make a big noise about a problem that may not have been that big of a problem," said Marvin M. Lipman, a Scarsdale, N.Y., physician and the chief medical adviser for Consumers Union. "In a sense, they've helped create the disease." The drug industry spent more than $4 billion in consumer advertising last year, a five-fold increase in 10 years. The U.S. is among a few countries that allow consumer advertising of prescription drugs. For years, pharmaceutical advertising was directed mainly at doctors and hospitals, but in 1997, the Food and Drug Administration issued guidelines for television advertising that helped spur a boom in commercials. Drug manufacturers say their ads are aimed at educating patients and doctors about diseases and available treatments, not necessarily to peddle their medicines. Chris Benecchi, the product manager at Lincolnshire, Ill.-based Takeda Pharmaceuticals North America Inc., maker of sleeping medication Rozerem, said the company goes to great lengths to educate doctors about other insomnia remedies. The drug's website lists several of them, for example. It is in a link just above the moving image of a man talking in his kitchen to Abraham Lincoln and a beaver with the tagline "Your dreams miss you." "Surveys show [consumer] advertising brings patients into their doctors' offices and helps start important doctor-patient conversations about conditions that might otherwise go undiagnosed or untreated," Ken Johnson, a senior vice president with industry trade group Pharmaceutical Research and Manufacturers of America, said in a written statement Monday. "Ultimately, it is doctors and patients together who should be making decisions on a patient's care, and to do that, they need the best information possible." Last year, Americans filled 43 million prescriptions for sleeping pills, up from 29 million in 2001. Sanofi-Aventis' Ambien, the best-selling sleeping pill, was the 14th most prescribed drug in the U.S., according to research firm IMS Health. Ambien, approved in 1992, grew from less than $1 billion in sales in 2001 to more than $2 billion last year. About 50 million to 70 million Americans suffer from insomnia, according to the Institute of Medicine at the National Academy of Sciences, but the causes are varied and not always clear. Insomnia is not a disease but a set of symptoms that is mostly triggered by other things like stress, pain or jet lag. Critics say consumer drug advertising is most questionable when hawking prescription medications that treat conditions like insomnia rather than particular ailments. By heavily promoting drugs that treat symptoms rather than illnesses, doctors say, patients may be driven to look for quick fixes instead of finding a solution. In most cases, doctors say, sleeping pills should be the last resort. But for many insomnia sufferers, that's the first thing they ask for when they enter a doctor's office. "When you see a commercial with the sun breaking over the hill and curtains opening and people with big grins on their faces and butterflies flying all around, sleeping pills become the treatment of first choice," said Lloyd Van Winkle, a family physician in Castroville, Texas. By contrast, ads for cholesterol-lowering drugs such as Pfizer Inc.'s Lipitor or AstraZeneca's Crestor are unlikely to drive someone without a cholesterol problem to request a prescription from a doctor. That's because someone either has high cholesterol or not. Doctors also credit advertising about cholesterol-lowering drugs with driving many people to check their cholesterol levels. Advertising can also promote the use of expensive prescription drugs by otherwise healthy people, critics say. Some users of Pfizer's Viagra and other drugs to treat erectile dysfunction are taking them simply to facilitate certain lifestyles. Doctors, the ultimate gatekeepers, are often too busy to argue with forceful patients or to spend much time diagnosing conditions that aren't life-threatening such as insomnia, medical experts said. Depressed Brain Can Be `Primed' Susan Brink, Los Angeles Times- 8/8/2006 Before the antidepressant ever gets swallowed, before it dissolves and makes its way through the bloodstream and deep within the gray matter of the brain, some depressed patients start feeling better because they think they will. Experiments have shown that healing from depression starts in some people, called placebo responders, even when the drug given is just a sugar pill. That, of course, is not enough to completely cure depression. But if a placebo can trick the brain into starting to get better, it's actually a pretty good predictor of who will continue to improve with antidepressant treatment. A new study released last week in the American Journal of Psychiatry shows that the placebo effect may provide a head start for actual drug treatment by beginning to change the brain pathways that antidepressants will then follow. The finding is an important step in helping scientists further refine who might be helped by drugs and what other factors might be involved in helping depressed patients get better. The setting most likely matters too. Feeling free to talk openly about how he felt, along with a belief that he was going to be helped, set Chuck Park, 32, of Culver City on a path to healing. He was a participant in the 51-person study and one of 26 volunteers who received a placebo for the entire nine weeks of the trial. Another 25 volunteers received antidepressants for eight of the nine weeks. "After a few weeks, I started to feel a little better," he says. "The nurse, Michelle, would ask me how I was feeling, and I knew it wasn't just a superficial question. I could really tell her." Activity measured by electroencephalogram in an area of the brain that is especially active in depressed patients, called the dorsolateral prefrontal cortex, slows down in some people shortly after they begin getting a placebo. The slowdown is not enough to overcome depression, but those people whose brains responded to sugar pills ended up also responding to antidepressants in the new study. And Park, who improved slightly on a placebo, saw his depression lift completely after the trial ended and he started taking antidepressants. "It's a very dramatic and clear example demonstrating that medication itself isn't the whole story," says Aimee M. Hunter, UCLA psychologist and lead author of the study. "If there is an actual formula or recipe for getting better, it may include medication, but it's very clear that it includes other factors or ingredients." The placebo response, as the study measured it, appears to be a significant ingredient. Researchers attributed about 19% of the mood improvements measured on a depression scale after the trial to the placebo effect. Psychiatric research is different from other kinds of medical research in that almost all depressed patients are given a placebo for about a week before the trial starts. Called the placebo lead-in, it is done to clear the body of other medications the patient might have been taking, but it is also done to get people used to filling out forms measuring their feelings and to allow them to meet the doctors and nurses who will be working with them. "Psychiatric studies are a lot more personal," says Dr. Andrew Leuchter, director of the laboratory of brain, behavior and pharmacology at UCLA. "This is the first study to look at succession," Leuchter says. "There are brain changes due to placebo, and changes due to the medication." But that still leaves 81% of the formula predicting treatment success yet to be sorted out. A patient's beliefs, hopes, expectations and relationship with the doctor might also play a role. Leuchter is part of a team of researchers in 10 centers throughout the country who are beginning to further sort out the elements that go into treating depression. They will study 300 patients to see if they can use similar EEG testing to predict which patients will do well on specific antidepressants. There are about 20 antidepressants available by prescription, and patients can fail on several before finding one that works. In fact, a National Institute of Mental Health sponsored study of 4,000 patients found that only about half of depressed patients got relief from their symptoms following a first round of treatment with either an antidepressant or talk therapy. "Right now, trial and error is the rule, and it can take months to find the right medication," says Leuchter. The new study he's involved with, called the Biomarkers for Rapid Identification of Treatment Effective in Major Depression trial, will look at brain changes following one week of treatment with any one of a number of antidepressants. That won't be enough time for the drugs to work clinically, but researchers will be looking for early brain changes. Volunteers will again be tested with EEGs after about three months of treatment. "We can look at early EEG changes to see if any of those changes predict how they did later," he says. If early brain changes can alert physicians to patients who are on the right track for treatment, Leuchter says, it could cut down on the time needed to find the right drug for the right patient. "We're hoping that within three years, this might be a test available in doctors' offices," he says. It's not just the right drug, either, that has yet to be sorted out. Depression is complicated and the NIMH is conducting a seven-year study, called the Sequenced Treatment Alternatives to Relieve Depression, to determine the effectiveness of various treatments, including drugs and psychotherapy and combinations of both. "We know from other studies that psychotherapy also causes certain brain changes," Leuchter says. "I believe that engagement with physicians and attention is a form of supportive therapy." It could be, he says, that just as drugs, placebo and talk therapy can change the brain's circuitry, so can wanting to get better, believing one will get better, or hearing a physician say there is great hope that you'll get better. |